SB3507 amends the Illinois Controlled Substances Act to require prescribers to access patient information in the Prescription Monitoring Program for.
SB3507 amends the Illinois Controlled Substances Act to mandate that prescribers or their designees document attempts to access patient information in the Prescription Monitoring Program when prescribing Schedule II and IV controlled substances. This requirement does not apply to inpatients, residents at hospitals, or institutional pharmacies. The bill also prohibits adverse actions against prescribers or dispensers based on patient feedback opposing clinical decisions, except for oncology treatment, palliative care, or short-term emergency supplies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.